Yozma

  • About

    • Overview

    • Yozma

    • The Global Offices

    • Success Stories

  • Investment

    • Strategy

    • A Value Added Investor

    • Value Added Investments

  • Portfolio

  • Team

  • News

  • Contact

  • Main
  • News

News

  • Admin
  • Feb 21 2025

[In the News]

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

https://finance.yahoo.com/news/alpha-tau-announces-cornerstone-interim-140000086.html?guccounter=1&guce_referrer=aHR0cHM6Ly9zdGliZWUuY29tLw&guce_referrer_sig=AQAAACZcMaGgG9ZwPxfpgluXXB9UZrJAomjR_TsjpNUCKVwwDd9CffRRW-DGKblzeZ5j3Z376Iqc-Y9kI3YtQqtpqfOGhZxqg
Previous
Maverick SDK 2.6.0, available as of November 25, 2024! Feb 07 2025
Next
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease Feb 21 2025
List

Please enter a prompt

Yozma
Family Site
  • YOZMA GROUP ASIA
  • YOZMA GROUP KOREA
ⓒ 2021 All Rights Reserved.
Yozma Address
9F, S&C Tower, 457 Bongeunsa-ro, Gangnam-gu, Seoul 06096, Republic of Korea
Email
orli@yozma.com
  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy
ⓒ 2021 All Rights Reserved.